
HIVäºé²ã®æ°ããªå€æãïŒYeztugoæ¿èªã®ç©èª ð
HIVäºé²ã®æ°ããªå€æãïŒYeztugoæ¿èªã®ç©èª ð 2025幎6æã®æããæãHIVãšã®éãã«ãããŠéèŠãªç¯ç®ãéæãããŸãããYeztugoïŒã¬ãã«ããã«ïŒãHIVäºé²ã®ããã®å幎ããšã®æ³šå°ãšããŠFDAã«æ¿èªãããããšã¯ãåžæãšé©æ°ã®æ°ããæä»£ãåãéããŸããããã®é©åœçãªäžæ©ã¯ãHIVäºé²ã®é¢šæ¯ãå€ããã ãã§ãªããå埩åãç§åŠã®åå©ããããŠããå¥åº·çãªæªæ¥ãžã®ããžã§ã³ããããããŸãã FDAæ¿èªãšåäŸã®ãªã广 ð Yeztugoã®FDAæ¿èªã¯ãPURPOSE 1ããã³PURPOSE 2ã®ç¬¬3çžè©Šéšããã®èª¬åŸåã®ãã蚌æ ã«åºã¥ããŠããŸãããããã®ç ç©¶ã¯ãã¯ã¯ãã³ãåããåå è ã®99.9%以äžãè©Šéšæéäžã«HIVã«ææããªãã£ãããšã瀺ããŸãããç¹ã«ãã¢ããªã«ã®å¥³æ§ã®éã§HIVã®çäŸã¯å ±åããããç·æ§ã倿§ãªæ§å¥ã®éã§ã¯ããã2äŸã®ã¿ã芳å¯ãããŸããããã®æåã®ç©èªã¯ãå»çç§åŠã®åéã«ããã驿°ã®åãšè§£æ±ºçã远æ±ãããããŸã¬åªåã®èšŒã§ãã "æªæ¥ã¯èªåã®å€¢ã®çŸãããä¿¡ããè ã«å±ããã" - ãšã¬ãã¢ã»ã«ãŒãºãã«ã ãŠããŒã¯ãªã¡ã«ããºã ãšè£œå€ã®å©ç¹ 𧬠Yeztugoã®å¹æã¯ãã«ãã·ãé»å®³å€ãšããŠã®é©æ°çãªã¡ã«ããºã ã«ãããŸããHIVã«ãã·ãã¿ã³ãã¯è³ªãæšçã«ããŠãŠã€ã«ã¹ã®äŸµå ¥ãšè€è£œã®åææ®µéããããã¯ããŸãããã®æ°ããã¢ãããŒãã«ããã幎éããã2åã®æ³šå°ã§æç¶çãªä¿è·å¹æãåŸãããæ¯æ¥ã®PrEPãææ¬¡æ³šå°ãšã¯äžç·ãç»ããŸããæäžåæ°ãå°ãªããããæ£è ã®éµå®çãå€§å¹ ã«åäžããããšãæåŸ ãããHIVäºé²æŠç¥ã«ãããã²ãŒã ãã§ã³ãžã£ãŒãšãªããŸãã "ç§åŠã¯ç§ãã¡ã®æªæ¥ãžã®éµã§ãããç§åŠãä¿¡ããªããªãã°ãçãåŸéãããŠããããšã«ãªãã" - ãã«ã»ã〠ã°ããŒãã«ãªèŠç¹ãšèª²é¡ ð Gileadã¯ãYeztugoã120以äžã®åœã§ãžã§ããªãã¯çç£ãšå ±ã«æäŸããããšãçŽæããŠããŸãããçŽ28,218ãã«ãšããé«é¡ãªè²»çšã倧ããªéå£ãšãªã£ãŠããŸããWHOãšGileadã¯ãäœæåŸåœã§ã®è¿ éãã€æé ãªã¢ã¯ã»ã¹ã確ä¿ããããã®æŠç¥ã«åãçµãã§ããŸããPEPFARãUSAIDã®ãããªããã°ã©ã ãžã®åœ±é¿ã«é¢ããæžå¿µã¯ãã°ããŒãã«ãªäºé²åªåãæ¯ããããã®åŒ·åºãªã€ã³ãã©ã®å¿ èŠæ§ã匷調ããŠããŸãã 120以äžã®åœã§ã®ã¢ã¯ã»ã¹ãžã®ã³ãããã¡ã³ã ç±³åœããã³ãšãŒãããã§ã®é«ã³ã¹ãã®èª²é¡ æé ãªè§£æ±ºçã®ããã®WHOãšã®åå "å€åãçè§£ããå¯äžã®æ¹æ³ã¯ãããã«é£ã³èŸŒã¿ããããšå ±ã«åãããã³ã¹ã«åå ããããšã ã" - ã¢ã©ã³ã»ã¯ãã åžæã«æºã¡ãå°å¹³ ð YeztugoãHIVäºé²ãå€é©ããæ ã«ä¹ãåºãäžã§ãäœçŸäžãã®äººã ã®åžæãšå€¢ãæ ã£ãŠããŸããç§åŠçã®ç®èº«ãšæŠç¥çãªã°ããŒãã«ããŒãããŒã·ãããçµã¿åããããHIVäºé²ãã¢ã¯ã»ã¹å¯èœã§å¹æçãã€å æ¬çãªæªæ¥ãçŽæããŸãããã®é©æ°ãšå¿èã®ç©èªã¯ãHIVã®åœ±ããè§£æŸãããäžçãžã®éãç §ããåžæã®ç¯å°ãšããŠæ©èœããŸãã





